China National Medicines Corporation Ltd. (SHA:600511)

SHA:600511 Revenue

China National Medicines Corporation had revenue of 13.27B CNY in the quarter ending September 30, 2024, with 7.12% growth. This brings the company's revenue in the last twelve months to 51.19B, up 7.81% year-over-year. In the year 2023, China National Medicines Corporation had annual revenue of 49.70B with 9.23% growth.

• Revenue (ttm): 51.19B
• Revenue Growth: +7.81%
• P/S Ratio: 0.45
• Revenue / Employee: 16.31M
• Employees: 3,138
• Market Cap: 22.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	49.70B	4.20B	9.23%
Dec 31, 2022	45.50B	-970.02M	-2.09%
Dec 31, 2021	46.47B	6.09B	15.08%
Dec 31, 2020	40.38B	-4.27B	-9.56%
Dec 31, 2019	44.64B	5.90B	15.24%